VanEck Pharmaceutical ETF PPH
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.36%
- Net assets
- $879.5M
- Holdings
- 26
- 12-month distribution yield
- 1.84%
- Asset class
- Equity
VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund listed on the Nasdaq in the United States, issued by VanEck. Its category is Equity · Global (equity). Its last price was US$116.34 on 20 Oct 2026. Its expense ratio is 0.36% a year, from its prospectus dated 1 Feb 2026. It reported net assets of US$879.46 million as of 30 Jun 2026. Its latest holdings report lists 26 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$2.14 a unit, a 12-month distribution yield of 1.84%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 0.36%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.35%
- Prospectus date
- 1 Feb 2026
- Filed with the SEC
- 27 Jan 2026
Size and reporting
- Net assets
- $879,456,644
- Total assets
- $882,186,406
- Holdings as of
- 30 Jun 2026
- Report made public
- 26 Aug 2026 (57 days after the month end)
Top holdings
Largest 25 of 26 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 20.23% | $177.9M | Equity (common) | United States | USD |
| 2 | Novartis AG | US66987V1098 | 10.63% | $93.4M | Equity (common) | Switzerland | USD |
| 3 | Merck & Co Inc | US58933Y1055 | 9.85% | $86.6M | Equity (common) | United States | USD |
| 4 | Novo Nordisk A/S | US6701002056 | 5.37% | $47.2M | Equity (common) | Denmark | USD |
| 5 | AbbVie Inc | US00287Y1091 | 4.57% | $40.2M | Equity (common) | United States | USD |
| 6 | Pfizer Inc | US7170811035 | 4.51% | $39.6M | Equity (common) | United States | USD |
| 7 | Bristol-Myers Squibb Co | US1101221083 | 4.47% | $39.3M | Equity (common) | United States | USD |
| 8 | GSK PLC | US37733W2044 | 4.42% | $38.9M | Equity (common) | United Kingdom | USD |
| 9 | Johnson & Johnson | US4781601046 | 4.35% | $38.3M | Equity (common) | United States | USD |
| 10 | AstraZeneca PLC | GB0009895292 | 4.33% | $38.1M | Equity (common) | United Kingdom | USD |
| 11 | McKesson Corp | US58155Q1031 | 4.12% | $36.3M | Equity (common) | United States | USD |
| 12 | Sanofi SA | US80105N1054 | 4.00% | $35.2M | Equity (common) | France | USD |
| 13 | Cencora Inc | US03073E1055 | 3.36% | $29.5M | Equity (common) | United States | USD |
| 14 | Haleon PLC | US4055521003 | 3.09% | $27.2M | Equity (common) | United Kingdom | USD |
| 15 | Teva Pharmaceutical Industries Ltd | US8816242098 | 3.06% | $26.9M | Equity (common) | Israel | USD |
| 16 | Takeda Pharmaceutical Co Ltd | US8740602052 | 2.87% | $25.3M | Equity (common) | Japan | USD |
| 17 | Zoetis Inc | US98978V1035 | 2.10% | $18.5M | Equity (common) | United States | USD |
| 18 | Viatris Inc | US92556V1061 | 1.10% | $9.6M | Equity (common) | United States | USD |
| 19 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | 1.08% | $9.5M | Equity (common) | Ireland | USD |
| 20 | Axsome Therapeutics Inc | US05464T1043 | 0.77% | $6.8M | Equity (common) | United States | USD |
| 21 | Corcept Therapeutics Inc | US2183521028 | 0.50% | $4.4M | Equity (common) | United States | USD |
| 22 | Elanco Animal Health Inc | US28414H1032 | 0.35% | $3.1M | Equity (common) | United States | USD |
| 23 | State Street Global Advisors State Street Navigator Securities Lending Government Money Market Portfolio | US8575093013 | 0.28% | $2.4M | Short-term investment vehicles (cash funds) | United States | USD |
| 24 | Organon & Co | US68622V1061 | 0.23% | $2.0M | Equity (common) | United States | USD |
| 25 | Bausch Health Cos Inc | CA0717341071 | 0.10% | $861K | Equity (common) | Canada | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.51% | |
| Short-term investment vehicles (cash funds) | 0.28% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 60.78% | |
| United Kingdom | 11.84% | |
| Switzerland | 10.63% | |
| Denmark | 5.37% | |
| France | 4.00% | |
| Israel | 3.06% | |
| Japan | 2.87% | |
| Ireland | 1.14% | |
| Canada | 0.10% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.79% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 90.95% | |
| Consumer Discretionary | 3.09% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $2.1400
- 12-month yield
- 1.84%
- Frequency
- Quarterly
- Latest ex-date
- 1 Oct 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($2.1400) ÷ latest price ($116.34) × 100 = 1.84%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (20 payments)
| Ex-date | Amount per unit |
|---|---|
| 1 Oct 2026 | $0.3600 |
| 1 Jul 2026 | $0.6250 |
| 1 Apr 2026 | $0.8440 |
| 29 Dec 2025 | $0.3110 |
| 1 Oct 2025 | $0.3930 |
| 1 Jul 2025 | $0.6070 |
| 1 Apr 2025 | $0.5250 |
| 27 Dec 2024 | $0.4110 |
| 1 Oct 2024 | $0.4090 |
| 1 Jul 2024 | $0.3560 |
| 1 Apr 2024 | $0.5330 |
| 27 Dec 2023 | $0.3070 |
| 2 Oct 2023 | $0.3400 |
| 3 Jul 2023 | $0.3890 |
| 3 Apr 2023 | $0.6640 |
| 28 Dec 2022 | $0.2400 |
| 3 Oct 2022 | $0.2700 |
| 1 Jul 2022 | $0.2500 |
| 1 Apr 2022 | $0.4430 |
| 29 Dec 2021 | $0.2690 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000034409) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- PPH and VT Vanguard Total World Stock Index ETF
- PPH and SMH VanEck Semiconductor ETF
- PPH and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- PPH and CGDV Capital Group Dividend Value ETF